Zobrazeno 1 - 10
of 16
pro vyhledávání: '"D S Badmazhapova"'
Autor:
N G CHERNOVA, E E ZVONKOV, D S BADMAZHAPOVA, M N SINITSYNA, L A GREBENYUK, Y V SIDOROVA, I E KOSTINA, A M KOVRIGINA, T N OBUKHOVA, A B SUDARIKOV, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 77-81 (2018)
Nodal anaplastic ALK-negative large cell lymphoma (nALCL, ALK-) is a Т-cell lymphoma that is characterized by aggressive clinical course and low sensitivity to СНОР (cyclophosphamide, doxorubicin, vincristine, prednisolone) and other chemotherap
Externí odkaz:
https://doaj.org/article/e9ba462d8d304be8a6be0d343c1661cf
Autor:
N G CHERNOVA, N P SOBOLEVA, S A MARIINA, Y V SIDOROVA, M N SINITSYNA, V N DVIRNYK, D S BADMAZHAPOVA, Y E VINOGRADOVA, E E ZVONKOV, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 51-56 (2018)
Contex. Angioimmunoblastic T-cell lymphoma (AITL) is a rare form of non-Hodgkins lymphoma, characterized by generalized lymphadenopathy, hepatosplenomegaly and dysproteinemia. Hypergammaglobulinaemia is revealed in 50-83% pts with AITL. However, the
Externí odkaz:
https://doaj.org/article/c60d2a7924bc4112967d0c4ce8a16e0d
Autor:
N G Chernova, E E Zvonkov, A M Kovrigina, A B Sudarikov, D S Badmazhapova, N G Gabeeva, T N Obukhova, S R Karagyulyan, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 93-98 (2017)
Breast implant-associated anaplastic large-cell lymphoma will be identified as a separate nosological entity in the 2017 adapted WHO classification due to differences in its clinical presentations, pathogenesis, and prognosis with those of nodal and
Externí odkaz:
https://doaj.org/article/cfcaa51cbca1434a89f13b93d808adf5
Autor:
V V Troitskaya, E N Parovichnikova, A N Sokolov, A V Kokhno, L A Kuzmina, D S Badmazhapova, Z T Fidarova, O A Gavrilina, A A Sidorova, G M Galstyan, S A Keselman, T V Gaponova, V S Galuzyak, S K Kravchenko, E O Gribanova, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 33-40 (2015)
Aim. To evaluate the efficiency of the treatment policy for patients with acute myeloid leukemia (AML) and hyperleukocytosis (HL), which is aimed at preventing rapid hypercytolysis and massive tumor lysis (cytolysis) syndrome and/or at reducing the d
Externí odkaz:
https://doaj.org/article/8267e2799105405f9dace82189c90369
Autor:
D. S. Badmazhapova, I. V. Galtseva, E. E. Zvonkov, Yu. O. Davydova, M. M. Kapranov, T. N. Moiseeva, A. M. Kovrigina, U. L. Julhakyan, K. I. Danishyan, K. R. Sabirov, E. N. Parovichnikova, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 15, Iss 4, Pp 18-28 (2020)
Background. Splenic marginal zone lymphoma (SMZL) is an indolent non-Hodgkin’s B-cell lymphoma. It presents morphologically by mature lymphoid B-cells. They conform to these immunological characteristics of marginal zone lymphocytes from secondary
Externí odkaz:
https://doaj.org/article/fc8dd7e701b246ce8459a6ee61591eb6
Autor:
D. S. Badmazhapova, I. V. Galtseva, E. Е. Zvonkov, Yu. O. Davydova, N. M. Kapranov, N. G. Chernova, N. G. Gabeeva, T. N. Moiseeva, A. M. Kovrigina, V. N. Dvirnyk, U. L. Dzhulakyan, E. N. Parovichnikova, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 13, Iss 1, Pp 103-114 (2018)
Background. Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disease that manifests by the accumulation of tumor monoclonal B-lymphocytes in the bone marrow, peripheral blood and secondary lymphoid organs. Recently it was found that CLL ce
Externí odkaz:
https://doaj.org/article/230dc4bc0d5d46638cc2318f5a5b0f1f
Autor:
N. G. Gabeeva, D. A. Koroleva, S. A. Tatarnikova, A. K. Smolianinova, D. S. Badmazhapova, S. Yu. Smirnova, E. E. Nikulina, A. V. Belyaeva, E. G. Gemdzhian, V. A. Lapin, E. R. Moskalets, I. E. Kostina, Y. K. Mangasarova, S. A. Shutov, B. V. Biderman, A. B. Sudarikov, T. N. Obukhova, A. M. Kovrigina, G. M. Galstyan, E. E. Zvonkov
Publikováno v:
Russian journal of hematology and transfusiology. 67:328-350
Introduction. Primary mediastinal lymphoma (PML) is an aggressive lymphoid tumor treatment success of which is determined by induction therapy. To date, none of the standard chemotherapy regimens (CT) have demonstrated an advantage in efficacy. Inte
Autor:
N G Chernova, L. F. Znamenskaya, L A Grebenyuk, E E Zvonkov, Alla M. Kovrigina, M. A. Nefedova, D S Badmazhapova, Valery G. Savchenko, Yu. V. Sidorova, A. A. Vorontsova, M. N. Sinitcina, A. E. Karamova
Publikováno v:
Vestnik Dermatologii i Venerologii, Vol 94, Iss 4, Pp 30-42 (2018)
The aim of the study is to present a successful case in treating primary cutaneous anaplastic large cell lymphoma (PCALCL) occurring with common lesions of the skin and lung tissue.Materials and methods. For the verification of the diagnosis in a pat
Autor:
I. E. Kostina, Alla M. Kovrigina, E E Zvonkov, L A Grebenyuk, M N Sinitsyna, N G Chernova, D S Badmazhapova, T N Obukhova, Valery G. Savchenko, Yu. V. Sidorova, Andrey Sudarikov
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 77-81 (2018)
Nodal anaplastic ALK-negative large cell lymphoma (nALCL, ALK-) is a Т-cell lymphoma that is characterized by aggressive clinical course and low sensitivity to СНОР (cyclophosphamide, doxorubicin, vincristine, prednisolone) and other chemotherap
Autor:
Yu E Vinogradova, N G Chernova, M N Sinitsyna, D S Badmazhapova, Valery G. Savchenko, E E Zvonkov, N P Soboleva, V N Dvirnyk, Yu. V. Sidorova, S A Mariina
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 51-56 (2018)
Contex. Angioimmunoblastic T-cell lymphoma (AITL) is a rare form of non-Hodgkins lymphoma, characterized by generalized lymphadenopathy, hepatosplenomegaly and dysproteinemia. Hypergammaglobulinaemia is revealed in 50-83% pts with AITL. However, the